LiveOne Issues Shares to BMI at Significant Premium to Settle Royalties and Extend Key Music Licenses

summarizeSummary

LiveOne, Inc. is issuing 1,000,000 shares to Broadcast Music, Inc. (BMI) at a premium of $7.50 per share to settle future music royalty obligations and extend critical license agreements, a move that significantly enhances the company's operational stability and liquidity.

check_boxKey Events

• Strategic Share Issuance to Settle Liabilities

  LiveOne is issuing 1,000,000 shares of common stock to Broadcast Music, Inc. (BMI) to fully satisfy all outstanding music royalty payment obligations through March 31, 2027, without any cash outlay from the company.

• Significant Premium Pricing

  The shares are being issued at a deemed price of $7.50 per share, which is a substantial premium compared to the last reported market price of $4.81 per share on April 20, 2026, indicating strong valuation by a key partner.

• Extension of Key Music Licenses

  This agreement also extends the term of essential music performance license agreements with BMI through December 31, 2027, ensuring continued access to critical content for LiveOne's services.

• Material Dilution to Shareholders

  The issuance of 1,000,000 shares will result in approximately 8.02% dilution to existing shareholders, increasing the total outstanding shares to 13,471,243.

auto_awesomeAnalysis

This prospectus supplement formalizes the issuance of 1,000,000 shares of common stock to Broadcast Music, Inc. (BMI) at a deemed price of $7.50 per share. This transaction, which was likely initiated by the 8-K filed on the same day, is highly significant for LiveOne, especially in light of its previously disclosed 'going concern' warning. By settling all outstanding music royalty obligations through March 2027 without expending cash, LiveOne substantially improves its liquidity and extends critical license agreements with BMI through December 2027. The issuance price of $7.50 per share represents a considerable premium over the last reported market price of $4.81, indicating strong confidence from a key industry partner. While the issuance results in approximately 8.02% dilution to existing shareholders, the strategic benefits of securing content rights, preserving cash, and addressing a major liability at favorable terms outweigh the dilutive effect, positioning the company more strongly to navigate its financial challenges.